NASDAQ:AEMD - Aethlon Medical Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.32 +0.05 (+3.94 %)
(As of 06/22/2018 08:00 AM ET)
Previous Close$1.27
Today's Range$1.28 - $1.32
52-Week Range$0.79 - $3.85
Volume59,700 shs
Average Volume91,047 shs
Market Capitalization$22.58 million
P/E RatioN/A
Dividend YieldN/A
Beta2.15
Aethlon Medical, Inc., a medical device company, focuses on creating devices that address unmet medical needs in health and biodefense worldwide. The company is developing Aethlon Hemopurifier, a clinical-stage therapeutic device for the single-use removal of life-threatening viruses from the circulatory system of infected individuals. It is also involved in the development of exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection. The company was founded in 1991 and is based in San Diego, California.

Receive AEMD News and Ratings via Email

Sign-up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AEMD
CUSIPN/A
Phone858-459-7800

Debt

Debt-to-Equity Ratio0.14
Current Ratio15.38
Quick Ratio15.38

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$150,000.00
Price / Sales156.29
Cash FlowN/A
Price / CashN/A
Book Value$0.36 per share
Price / Book3.67

Profitability

EPS (Most Recent Fiscal Year)($0.46)
Net Income$-5,670,000.00
Net MarginsN/A
Return on Equity-234.47%
Return on Assets-154.14%

Miscellaneous

Employees6
Outstanding Shares17,760,000

Aethlon Medical (NASDAQ:AEMD) Frequently Asked Questions

What is Aethlon Medical's stock symbol?

Aethlon Medical trades on the NASDAQ under the ticker symbol "AEMD."

How were Aethlon Medical's earnings last quarter?

Aethlon Medical, Inc. (NASDAQ:AEMD) posted its earnings results on Friday, June, 8th. The medical equipment provider reported ($0.06) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.10) by $0.04. The medical equipment provider had revenue of $0.07 million for the quarter, compared to analysts' expectations of $0.09 million. View Aethlon Medical's Earnings History.

What price target have analysts set for AEMD?

1 brokerages have issued twelve-month target prices for Aethlon Medical's stock. Their forecasts range from $3.00 to $3.00. On average, they anticipate Aethlon Medical's stock price to reach $3.00 in the next year. View Analyst Ratings for Aethlon Medical.

Who are some of Aethlon Medical's key competitors?

Who are Aethlon Medical's key executives?

Aethlon Medical's management team includes the folowing people:
  • Mr. James A. Joyce, Founder, CEO, Sec. & Director (Age 56)
  • Mr. Rodney S. Kenley, Pres & Director (Age 68)
  • Mr. James B. Frakes, CFO & Sr. VP of Fin., CHIEF ACCOUNTING OFFICER (Age 61)
  • Dr. Richard H. Tullis, Consultant (Age 73)
  • Dr. Annette Marleau, Director of Research (Age 43)

Has Aethlon Medical been receiving favorable news coverage?

News headlines about AEMD stock have been trending somewhat positive on Friday, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Aethlon Medical earned a media sentiment score of 0.18 on Accern's scale. They also assigned media headlines about the medical equipment provider an impact score of 45.75 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Who are Aethlon Medical's major shareholders?

Aethlon Medical's stock is owned by a number of of institutional and retail investors. Top institutional investors include Millennium Management LLC (1.20%). View Institutional Ownership Trends for Aethlon Medical.

Which institutional investors are buying Aethlon Medical stock?

AEMD stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC. View Insider Buying and Selling for Aethlon Medical.

How do I buy shares of Aethlon Medical?

Shares of AEMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aethlon Medical's stock price today?

One share of AEMD stock can currently be purchased for approximately $1.32.

How big of a company is Aethlon Medical?

Aethlon Medical has a market capitalization of $22.58 million and generates $150,000.00 in revenue each year. The medical equipment provider earns $-5,670,000.00 in net income (profit) each year or ($0.46) on an earnings per share basis. Aethlon Medical employs 6 workers across the globe.

How can I contact Aethlon Medical?

Aethlon Medical's mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The medical equipment provider can be reached via phone at 858-459-7800 or via email at [email protected]


MarketBeat Community Rating for Aethlon Medical (AEMD)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  85 (Vote Outperform)
Underperform Votes:  67 (Vote Underperform)
Total Votes:  152
MarketBeat's community ratings are surveys of what our community members think about Aethlon Medical and other stocks. Vote "Outperform" if you believe AEMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AEMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.